Evidence map›Paper›PMID 34574782›Full record

Observational studyInternational journal of environmental research and public health2021

Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in Spain.

Ruth Usó-Talamantes, Silvia González-de-Julián, Javier Díaz-Carnicero, Inmaculada Saurí-Ferrer, José Luis Trillo-Mata, Marc Carrasco-Pérez, Jorge Navarro-Pérez, José Luis Górriz, David Vivas-Consuelo, Josep Redón

Abstract readObservational Study
In one paragraph

Observational study in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2022 · on this map
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ruth Usó-TalamantesConselleria de Sanitat i Salut Pública, Generalitat Valenciana, 46010 Valencia, Spain.ORCID 0000-0002-6732-8495
Silvia González-de-JuliánResearch Unit for Health Economics and Management, Universitat Politècnica de València, 46022 Valencia, Spain.ORCID 0000-0003-0274-6060
Javier Díaz-CarniceroResearch Unit for Health Economics and Management, Universitat Politècnica de València, 46022 Valencia, Spain.
Inmaculada Saurí-FerrerINCLIVA Research Institute, 46010 Valencia, Spain.
José Luis Trillo-MataHospital Valencia Clínico-Malvarrosa, 46010 Valencia, Spain.ORCID 0000-0002-5851-9038
Marc Carrasco-PérezBoehringer Ingelheim España S.A., 08174 Barcelona, Spain.
Jorge Navarro-PérezINCLIVA Research Institute, 46010 Valencia, Spain.
José Luis GórrizINCLIVA Research Institute, 46010 Valencia, Spain.ORCID 0000-0002-1134-9051
David Vivas-ConsueloResearch Unit for Health Economics and Management, Universitat Politècnica de València, 46022 Valencia, Spain.ORCID 0000-0003-2945-7525
Josep RedónINCLIVA Research Institute, 46010 Valencia, Spain.ORCID 0000-0001-8777-6773

Funding

Boehringer Ingelheim España, S.A. n/a
6 · The paper itself

Abstract

This study analyzed the prevalence, costs and economic impact of chronic kidney disease CKD in patients with T2D in a Spanish Health District using real-world data. Observational cross-sectional study in adult patients with T2D was through data extracted from the information systems of the Valencia Clínico-La Malvarrosa Health District in the year 2015. Patients were stratified with the KDIGO classification for CKD. Additionally, patients were assigned to Clinical Risk Groups (CRGs) according to multimorbidity. Direct costs of primary and specialized care, and medication were estimated. The prevalence of T2D in the database population (

Indexed as

Diabetes Mellitus, Type 2Renal Insufficiency, ChronicAgedCross-Sectional StudiesFemaleHealth Care CostsHumansMaleSpainburden of carechronic kidney diseaseClinical Risk Groupscostshealthcare resourcesKDIGO classificationtype 2 diabetes

Identifiers

PMID34574782
PMCPMC8468968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.